Neuberger Berman Group LLC - OCULAR THERAPEUTIX INC ownership

OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 66 filers reported holding OCULAR THERAPEUTIX INC in Q1 2018. The put-call ratio across all filers is 0.56 and the average weighting 1.2%.

Quarter-by-quarter ownership
Neuberger Berman Group LLC ownership history of OCULAR THERAPEUTIX INC
ValueSharesWeighting
Q3 2022$213,000
+2.9%
51,400
-0.3%
0.00%
Q2 2022$207,000
-31.0%
51,550
-14.8%
0.00%
Q1 2022$300,000
-28.9%
60,510
-0.1%
0.00%
Q4 2021$422,000
-30.2%
60,543
+0.0%
0.00%
-100.0%
Q3 2021$605,000
-30.3%
60,539
-1.1%
0.00%0.0%
Q2 2021$868,000
-14.1%
61,189
-0.6%
0.00%0.0%
Q1 2021$1,010,000
-23.3%
61,539
-3.2%
0.00%0.0%
Q4 2020$1,316,000
+172.5%
63,590
+0.2%
0.00%0.0%
Q3 2020$483,000
-8.7%
63,490
+0.0%
0.00%0.0%
Q2 2020$529,000
+69.0%
63,460
+0.3%
0.00%
Q1 2020$313,000
+25.2%
63,2400.0%0.00%
Q4 2019$250,000
+22.5%
63,240
-5.9%
0.00%
Q3 2019$204,000
-31.1%
67,2400.0%0.00%
Q2 2019$296,000
+83.9%
67,240
+65.5%
0.00%
Q1 2019$161,000
-2.4%
40,640
-2.2%
0.00%
Q4 2018$165,000
-42.3%
41,5400.0%0.00%
Q3 2018$286,000
+8.3%
41,540
+6.1%
0.00%
Q2 2018$264,000
+3.5%
39,1650.0%0.00%
Q1 2018$255,000
+68.9%
39,165
+15.7%
0.00%
Q4 2017$151,000
-36.8%
33,865
-12.4%
0.00%
Q3 2017$239,000
-13.7%
38,665
+29.3%
0.00%
Q2 2017$277,00029,9000.00%
Other shareholders
OCULAR THERAPEUTIX INC shareholders Q1 2018
NameSharesValueWeighting ↓
SV Health Investors, LLC 1,932,607$40,643,00015.56%
Lamond Capital Partners LLC 711,533$14,964,00015.19%
Polaris Venture Management Co. V, L.L.C. 1,230,009$25,867,00011.54%
NOTTINGHAM ADVISORS, INC. 171,985$3,617,0000.60%
Portolan Capital Management 122,518$2,577,0000.36%
SPHERA FUNDS MANAGEMENT LTD. 160,000$3,365,0000.33%
Rotella Capital Management, Inc. 18,461$388,0000.32%
Monashee Investment Management LLC 28,834$606,0000.29%
DRIEHAUS CAPITAL MANAGEMENT LLC 335,498$7,056,0000.24%
BAILARD, INC. 55,000$1,157,0000.18%
View complete list of OCULAR THERAPEUTIX INC shareholders